More tools:Markets·Screener·Research·Chat

Celularity Inc. Class A Common Stock (CELU) Financial Statements

Celularity Inc. Class A Common Stock
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG00P2RTT43
XNAS · usd
1.44▼ 0.00 (-0.35%)
As of 2026-09-10
Valuation
Market Cap
Enterprise Value
Trailing P/E—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close1.44
Day's Range1.38 – 1.48
52-Week Range0.56 – 2.55
Volume152.5K
Avg Volume7.9M
Share Statistics
Shares Outstanding
Employees123
ExchangeXNAS
Listed2021-07-19
Share count as of April 28, 2026
Loading Income Statement…
Key questions about Celularity Inc. Class A Common Stock (CELU)
What is Celularity Inc. Class A Common Stock's Market Cap?
Celularity Inc. Class A Common Stock's Market Cap is $41.5M, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's Enterprise Value?
Celularity Inc. Class A Common Stock's Enterprise Value is $69.2M, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's Price / Sales?
Celularity Inc. Class A Common Stock's Price / Sales is 1.6×, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's EV / Revenue?
Celularity Inc. Class A Common Stock's EV / Revenue is 2.6×, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's EV / EBITDA?
Celularity Inc. Class A Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's Revenue (TTM)?
Celularity Inc. Class A Common Stock's Revenue (TTM) is $26.6M, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's Net Income (TTM)?
Celularity Inc. Class A Common Stock's Net Income (TTM) is -$91.7M, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's EBITDA?
Celularity Inc. Class A Common Stock's EBITDA is -$54.0M, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's Diluted EPS (TTM)?
Celularity Inc. Class A Common Stock's Diluted EPS (TTM) is -3.17, based on as-reported figures from SEC (XBRL) filings.
What is Celularity Inc. Class A Common Stock's EBITDA Margin?
Celularity Inc. Class A Common Stock's EBITDA Margin is -203.4%, based on as-reported figures from SEC (XBRL) filings.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022
Net revenues
Revenue
YoY growth-77.4%-43.2%-52.6%-22.2%
Cost of Revenue
Cost of Revenue
Research and Development Expense
Selling, General and Administrative Expense
Amortization of Intangibles———
Total operating expenses
Loss from operations
% of revenue-537.5%-244.1%-276.6%-91.8%
Other income (expense):
Non-Operating Income (Expense)
Interest expense
Change in fair value of warrant liabilities
Change in fair value of debt
Loss on issuance of convertible notes with warrants——
Total other expense
Loss before income taxes
Income Tax Expense————
Net loss
% of revenue-593.6%-436.7%-427.5%-172.9%
Net loss attributable to common shareholders
Earnings Per Share (Basic)
Earnings Per Share (Diluted)